Canada: A Look Back At 2014 Trends In Product Liability Class Proceedings

Last Updated: January 14 2015
Article by Carly Cohen and Leonard Loewith

Hello 2015 - From the Cassels Brock Product Liability Group, welcome back and we hope you enjoyed some time off this holiday season. What better way to greet the new year than with a look back over trends in product liability class actions from 2014.

This past year, claims against pharmaceutical and medical device manufacturers were on the rise, while claims against retailers for credit card and data breaches were less frequent (and therefore there were fewer claims against manufacturers for those same breaches in relation to their products). The plaintiff-friendly landscape for certification of pharmaceutical claims may be shifting, but that has not slowed the influx of class actions commenced against pharmaceutical manufacturers.

What follows is a look back on trends in product liability class proceedings during 2014.

Pharmaceutical Product Liability

Across Canada in 2014, at least 15 class proceedings were commenced alleging the failure to warn of the risks associated with the use of prescription drugs. These pharmaceutical product liability class proceedings include the following:

  • class actions seeking national class certification were brought in British Columbia1, Alberta2, Quebec3, Manitoba4 and Nova Scotia5 against Boehringer Ingelheim as the designer, manufacturer and distributor of the blood-thinner Pradaxa;
  • in Ontario alone, four separate class proceedings against designers, manufacturers and distributors of testosterone replacement therapy, including Merck and Pfizer, were filed. These actions alleged a failure to warn of the cardiovascular risks6;
  • a series of claims in respect of Risperdal and Invega, the antipsychotic medication used to treat schizophrenia and symptoms of bipolar disorder, were brought against Janssen in Ontario7, Quebec8, Alberta9 and Nova Scotia10 alleging the failure to warn of the increased risk of developing gynecomastia;
  • the designers, manufacturers and distributors of Accutane, an acne treatment prescription, were faced with a class proceeding in Ontario11; and
  • a class proceeding regarding Topamax, a prescription used to treat seizures, was brought against Johnson & Johnson in Saskatchewan alleging the failure to warn of the associated risks, namely the risk of birth defects and vision problems.12

While none of these class proceedings have moved to the certification stage, we anticipate that the plaintiffs that move their actions forward will likely have to satisfy a more rigorous analysis to be certified in light of the Martin v Astrazeneca Pharmaceuticals PLC13 decision. In that case, Justice Horkins of the Ontario Superior Court did not certify a proposed national class action involving the antipsychotic medication Seroquel. In contrast to the low-hurdle for certification seen in previous years, the Court found that the plaintiffs failed to meet the necessary criteria and noted that the certification of similar issues in other cases is not sufficient to warrant certification in every case. So why is this decision relevant? It was upheld on appeal and suggests that Ontario courts may take a more rigorous approach in applying certification standards.

Implanted Medical Device Product Liability

Manufacturers and distributors of implanted medical products were increasing targets in class proceedings in 2014. Manufacturers in the medical device industry have been under attack for the failure to, among other things:

  • properly design and manufacture the implanted medical device;
  • conduct adequate testing before placing the device on the market; and
  • warn of the risks associated with implanting the medical device.

In two Quebec proceedings,14 the plaintiffs brought claims against the manufacturers and distributors of pelvic mesh products implanted in the uteri of female patients. Actions for defective implanted hip replacement devices also continued into 2014. In Mary Chipman v Biomet, Inc. et al,15 a Nova Scotia action, the plaintiff seeks to certify class proceedings against the manufacturer of the hip implant system. Similar claims were also brought against Biomet16 and Smith & Nephew in 2013.17

The actions come on the coattails of the Depuy decision18, in which the Ontario Superior Court certified a class action against a manufacturer of surgically implanted hip replacements. The case marked a more generous approach to the certification of medical device class actions after a series of earlier cases that had applied a more cautious approach. In light of the certification, we expect that other implanted medical devices will come under fire, but it stands to be seen whether the actions will continue to be met with plaintiff-friendly courts.

Credit Card and Data Breach Product Liability

In the past years, credit card and data breaches by hackers have been noted frequently in the media, which has resulted in a flurry of class proceedings. While 2014 saw a decline in these attacks and corresponding class actions, manufacturers of hardware must still take caution that their products meet all necessary security requirements.

From 2011 to 2013, we saw many class actions filed following data breaches. The first was commenced against Sony Playstation Network after a privacy breach of millions of its users. In this case, the class members alleged negligence in the storage and security of their credit card data. We also saw a class proceeding commenced on behalf of all Canadian residents whose electronic data and communications were intercepted by Google Street View vehicles between 2009-2010,20 alleging intentional or negligent interception of data.

TD Auto Finance Services' loss of a data tape containing customers' personal and credit information led to a class proceeding in 2012.21 Members of the class claimed that they fell victim to identity fraud before the company notified those at risk.

When a portable hard drive was stolen in late 2012, 583,000 Canada Student Loan borrowers had finance and credit information compromised, including their SIN numbers.22 Negligence and breach of confidence and fiduciary duty were pleaded in the subsequent class action. Another class action was filed in the Federal Court for breach of contract, breach of warranty, breach of confidence, reckless intrusion upon seclusion and negligence.23

To date, there have been 641 reported breaches of consumer data in the U.S. alone.24 Data breaches are no less prevalent in Canada: 36% of IT professionals surveyed reported that their companies had been the targets of data breaches.25

Most notably in 2014, hackers stole the card data of 56 million Home Depot customers. Despite an increase in data breaches in 2014, class action litigation alleging damages from negligence and intrusion into one's privacy has decreased.26 In 2014, only the Home Depot class action was commenced. In that case, customers who used credit or debit cards between April and August 2014 claimed for damages.

Despite the trend of class actions being commenced in respect of data breaches, there has been a drop off in such claims in 2014. Why? One reason could be the lack of certainty among plaintiff-side class action firms as to whether these proceedings will be certified – none of the above mentioned cases have been tested by the courts.

It is hard to say if a class action is the best method for data breach claims. In assessing whether a class action is the preferable means, the courts will consider whether the process will achieve a just and effective remedy. With the increase of data breach incidences, companies have become better at recognizing breaches and taking immediate steps to remedy potential damage. When a company recognizes a breach of confidential data, notifies its customers promptly and implements remedies to mitigate or prevent losses, the courts may view these steps as an appropriate and efficient substitute to a class proceeding.

While there remains a risk of data breaches, the trend of class proceedings following such breaches will continue to be selective, due, in part, to the proactive and face-saving steps taken by some of the companies under attack.


1. Marilyn Tanguay, Personal Representative of the Estate of Gladys Choinard, Deceased v Boehringer Ingelham (Canada) Ltd et al, (Supreme Court of British Columbia), Court File No. S-145515; George Stathis v Boehringer Ingelham (Canada) Ltd et al, Supreme Court of British Columbia, Court File No. 14-2104.

2. Dimitre Stoianov Karpuzov v Boehringer Ingelham (Canada) Ltd et al, Court of Queen's Bench of Alberta, Court File No. 1401-09615.

3. Denis Lebel v Boehringer Ingelham (Canada) Ltd et al, Quebec Superior Court (Class Action), Court file no. 500-06-000.

4. The Estate of Susan Darlene Gareau et al v Boehringer Ingelham (Canada) Ltd et al, Manitoba Court of Queen's Bench, Court File No. C114.01.87568.

5. Dawn Rae Downton as executor of the Estate of Marion Wiseman v Boehringer Ingelham (Canada) Ltd et al, Supreme Court of Nova Scotia, Court File No. 428996.

6. Nault v Merck & Co, Inc et al, Ontario Superior Court of Justice, Court File No. 3969/14CP; Edward Michael Gater et al v Pfizer Inc et al, Ontario Superior Court of Justice, Court File No. 3737/14CP; Marie Anne Tonasket Denommee v Endo Pharmaceuticals Solutions Inc et al, Ontario Superior Court of Justice, Court File No. 3704CP/14; Norman Douglas Wise et al v Abbott Laboratories, Limited at al, Ontario Superior Court of Justice, Court File No. 3547/14CP.

7. Nicholas Brown v Janssen Inc et al, Ontario Superior Court of Justice, Court File No. CV-14-496160-00CP.

8. Lebouthillier et al v Janssen Inc et al, Superior Court of Quebec (Class Action ), Court File No. unknown.

9. Joel Avery Macdonald v Janssen Inc et al, Court of Queen's Bench of Alberta, Court File No. 1401-08697.

10. Ryan Hanna v Janssen Inc et al, Supreme Court of Nova Scotia, Court File No. 429715.

11. Brad Stevenson v. Hoffman-La Roche Limited, Ontario Superior Court of Justice, Court File No. CV-10-41206500CP.

12. Barbara Reiner v Johnson & Johnson et al, Court of Queen's Bench for Saskatchewan, Court File No.QBG-578

13. Martin v Astrazeneca Pharmaceuticals Plc, 2012 ONSC 2744, upheld 2013 ONSC 1169.

14. Sharon Rosemary McKee & Hans McKee c. Tyco Healthcase Group Canada ULC d/b/a/ Covidien, Quebec Superior Court (Class Action), Court File No. 200-06-000173-149; Pauline Sirois & Réjean Dumont c. American Medical Systems Canada inc. et al., Quebec Superior Court (Class Action), Court File No. 200-06-000178-148.

15. Mary Chipman v Biomet, Inc et al, Supreme Court of Nova Scotia, Court File No. 426867.

16. Steven Dalton Dine v Biomet, Inc et al, Ontario Superior Court of Justice, Court File No. CV-10-415755-00CP.

17. Gary Carlson v Smith & Nephew Inc. of Canada et al, Supreme Court of British Columbia, Court File No. S-139332; Milana Warner v Smith & Nephew Inc, Court of Queen's Bench of Alberta, Court File No. 1301 01931.

18. Crisante v DePuy Orthopaedics Inc, 2013 ONSC 5186.

19. Youval Benabou v Sony of Canada Ltd., Sony Computer Entertainment America LLC, and Sony Network Entertainment International LLC, 2011, Quebec Superior Court (Class Action), Court File No. 500-06-000566-113.

20. M Elkoby v Google, Inc. and Google Canada Corporation, 2011, Quebec Superior Court (Class Action), Court File No. 500-06-000567-111.

21. M Belley v TD Auto Finance Services Inc., 2012, Quebec Superior Court (Class Action), Court File No. 500-006-06-000615-126.

22. Tonia Bogart v The Minister of Human Resources and Skills Development Canada and The Attorney General of Canada, 2013, Court of Queen's Bench of Alberta, Action Number 1301-00732.

23. Gaelen Patrick Condon, Rebecca Walker, and Angela Piggot v Her Majesty the Queen, 2013, Federal Court (Proposed Class Proceeding), Court File No. T-132-13.


25. Paddon, David, Data Breaches Rampant in Canada (19 August 2014), online: The Hamilton Spectator (

26. 2014 Data Breaches (23 October 2014), online: Identity Theft Resource Center (

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Carly Cohen
In association with
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.